Cite
HARVARD Citation
Ranea‐Robles, P. et al. (2018). Aberrant regulation of the GSK‐3β/NRF2 axis unveils a novel therapy for adrenoleukodystrophy. EMBO molecular medicine. 10 (8), p. n/a. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Ranea‐Robles, P. et al. (2018). Aberrant regulation of the GSK‐3β/NRF2 axis unveils a novel therapy for adrenoleukodystrophy. EMBO molecular medicine. 10 (8), p. n/a. [Online].